Department of Systems Biology, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Department of Pediatric Oncology, Dana-Farber Cancer Institute-Harvard Medical School, Boston, MA, USA.
Nat Commun. 2021 Jul 1;12(1):4063. doi: 10.1038/s41467-021-24324-0.
Identification of novel functional domains and characterization of detailed regulatory mechanisms in cancer-driving genes is critical for advanced cancer therapy. To date, CRISPR gene editing has primarily been applied to defining the role of individual genes. Recently, high-density mutagenesis via CRISPR tiling of gene-coding exons has been demonstrated to identify functional regions in genes. Furthermore, breakthroughs in combining CRISPR library screens with single-cell droplet RNA sequencing (sc-RNAseq) platforms have revealed the capacity to monitor gene expression changes upon genetic perturbations at single-cell resolution. Here, we present "sc-Tiling," which integrates a CRISPR gene-tiling screen with single-cell transcriptomic and protein structural analyses. Distinct from other reported single-cell CRISPR screens focused on observing gene function and gene-to-gene/enhancer-to-gene regulation, sc-Tiling enables the capacity to identify regulatory mechanisms within a gene-coding region that dictate gene activity and therapeutic response.
鉴定致癌基因中新的功能结构域和详细的调控机制对于先进的癌症治疗至关重要。迄今为止,CRISPR 基因编辑主要应用于确定单个基因的作用。最近,通过 CRISPR 基因编码外显子的高密度诱变已经证明可以鉴定基因中的功能区域。此外,将 CRISPR 文库筛选与单细胞液滴 RNA 测序 (sc-RNAseq) 平台相结合的突破,揭示了在单细胞分辨率下监测遗传干扰时基因表达变化的能力。在这里,我们提出了“sc-Tiling”,它将 CRISPR 基因平铺筛选与单细胞转录组和蛋白质结构分析相结合。与其他报道的专注于观察基因功能和基因间/增强子-基因调控的单细胞 CRISPR 筛选不同,sc-Tiling 能够识别编码区域内调节基因活性和治疗反应的调控机制。